SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Ipsen's Partner, Inspiration Biopharmaceuticals, Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B and Will Receive $35 Million